Since it has previously been observed that PIM1 over-expression can exert a pro-survival activity in prostate cancer cells treated with chemoterapeutic drugs [40], [41], we tried to assess whether this phenomenon can be observed also in the non-tumoral RWPE-1 model. The gene discussed is PIM1; the disease is Familial prostate cancer.